封面
市場調查報告書
商品編碼
1900590

小動物影像(體內)市場規模、佔有率和成長分析(按成像方式、試劑、應用、最終用戶和地區分類)-2026-2033年產業預測

Small Animal Imaging In Vivo Market Size, Share, and Growth Analysis, By Modality (Optical Imaging Systems, Nuclear Imaging Systems), By Reagents, By Application, By End-User, By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 224 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球小動物體內影像市場規模預計在 2024 年達到 11.5 億美元,從 2025 年的 12.4 億美元成長到 2033 年的 22.7 億美元,在預測期(2026-2033 年)內複合年成長率為 7.8%。

隨著微型磁振造影(micro-MRI)、微型電腦斷層掃描(micro-CT)和微型正子斷層掃描(micro-PET)等各種核子醫學成像技術發展成為先進的微型儀器,全球小型動物影像市場正經歷顯著的進步。多模態成像技術(包括微型超音波和光學成像)的發展,以及臨床前研究的增加和受託研究機構(CRO)投資的成長,都推動了這一趨勢。然而,嚴格的監管要求和不完善的報銷機制等挑戰可能會阻礙市場擴張。儘管有這些限制,但價格較親民的技術的出現有望推動市場成長,尤其是在新興市場。北美憑藉其先進的技術應用和有利的政策,在該領域處於領先地位,而亞太地區正在迅速崛起,為小動物成像領域的公司提供了巨大的機會。

推動全球小動物體內影像市場發展的因素

全球小型動物生物成像市場預計將迎來顯著成長,主要驅動力在於多模態成像技術的日益普及。這些先進的成像解決方案因其能夠提供對生物過程的全面洞察而備受關注。此外,醫療保健領域預算的增加也推動了對專用於小型動物的尖端成像設備的投資,從而增強了研究能力並加速了獸醫學的發展。技術創新和資金支持的共同作用預計將為小型動物成像市場在不久的將來蓬勃發展創造有利環境。

限制全球小動物影像與體內市場發展的因素

全球小型動物生物成像市場面臨許多挑戰,可能阻礙其擴張。高昂的設備成本和技術限制構成了市場准入和發展的巨大障礙。此外,開發中國家熟練專業人員的短缺進一步加劇了這一局面。加之研究設施和基礎設施的匱乏,這些因素共同限制了市場的潛在成長。隨著該領域的不斷進步,應對這些挑戰對於確保研究人員和機構擁有更強大、更便利的小型動物影像環境至關重要。若缺乏策略性解決方案,市場可能難以在這些限制條件下充分發揮其潛力。

全球小動物影像與體內市場趨勢

全球小型動物體內影像市場正經歷顯著成長,這主要得益於研究人員和製藥公司對非侵入性成像技術日益成長的需求。公共和私人機構不斷增加的資金投入也為這一快速成長提供了支持,推動了化學、電腦科學、工程和分子生物學等多個領域的進步。此外,研究機構的擴張及其對創新技術的關注也推動了市場的動態。新興經濟體正在創造新的成長機遇,加之對舉措的高度重視,預計小型動物影像市場將持續維持成長動能。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 技術進步
  • 監管環境

全球小動物影像(體內)市場規模(按成像方式和複合年成長率分類)(2026-2033 年)

  • 光學成像系統
    • 生物發光成像
    • 螢光影像
  • 核子醫學掃描術診斷系統
    • 正子斷層掃描(PET)
    • 單光子發射電腦斷層掃描(SPECT)
  • 磁振造影(MRI)系統
  • 電腦斷層掃描(CT)系統
  • 超音波成像系統
  • 光聲成像系統

全球小動物成像(體內)市場規模(按試劑和複合年成長率分類)(2026-2033 年)

  • 光學成像試劑
  • 核子醫學影像試劑
  • 磁振造影劑
  • 超音波造影劑
  • CT造影劑

全球小動物影像(體內)市場規模(按應用及複合年成長率分類)(2026-2033 年)

  • 生物分佈研究
  • 癌細胞檢測
  • 生物標記
  • 縱貫研究
  • 藥物研發
  • 功能和解剖成像

全球小型動物影像(體內)市場規模(以最終用戶分類)及複合年成長率(2026-2033 年)

  • 製藥和生物技術公司
  • 學術研究機構
  • 合約研究組織(CRO)
  • 醫院和診所

全球小動物影像(體內)市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Bruker Corporation(US)
  • PerkinElmer, Inc.(US)
  • FUJIFILM Holdings Corporation(Japan)
  • Siemens Healthineers AG(Germany)
  • Miltenyi Biotec(Germany)
  • Aspect Imaging(Israel)
  • Thermo Fisher Scientific Inc.(US)
  • GE Healthcare(US)
  • Mediso Ltd.(Hungary)
  • MR Solutions Ltd.(UK)
  • TriFoil Imaging(US)
  • Key Developments
  • Agilent Technologies, Inc.(US)
  • Hitachi Ltd.(Japan)
  • Canon Medical Systems Corporation(Japan)

結論與建議

簡介目錄
Product Code: SQSG35A2089

Global Small Animal Imaging In Vivo Market size was valued at USD 1.15 Billion in 2024 and is poised to grow from USD 1.24 Billion in 2025 to USD 2.27 Billion by 2033, growing at a CAGR of 7.8% during the forecast period (2026-2033).

The global small animal imaging market is witnessing significant advancements, driven by various nuclear imaging technologies like micro MRI, micro CT, and micro PET, which have evolved into sophisticated micro-level equipment. Growth in multimodal imaging, including micro-ultrasound and optical imaging, coupled with increased pre-clinical research and investments from contract research organizations (CROs), supports this trend. However, challenges such as stringent regulatory requirements and inadequate reimbursement scenarios could hinder expansion. Despite these limitations, the rise of affordable technologies is anticipated to promote growth, especially in emerging markets. North America leads this sector due to its advanced technology adoption and favorable policies, but the Asia-Pacific region is emerging rapidly, representing substantial opportunities for companies in the small animal imaging field.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Small Animal Imaging In Vivo market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Small Animal Imaging In Vivo Market Segments Analysis

Global Small Animal Imaging In Vivo Market is segmented by Modality, Reagents, Application, End-User and region. Based on Modality, the market is segmented into Optical Imaging Systems, Nuclear Imaging Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Systems, Ultrasound Imaging Systems and Photoacoustic Imaging Systems. Based on Reagents, the market is segmented into Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents and CT Contrast Agents. Based on Application, the market is segmented into Biodistribution Studies, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Drug Development and Functional and Anatomical Imaging. Based on End-User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs) and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Small Animal Imaging In Vivo Market

The market for global small animal imaging in vivo is poised for significant growth, largely driven by the increasing adoption of multimodal imaging technologies. These advanced imaging solutions are gaining traction due to their ability to provide comprehensive insights into biological processes. Furthermore, the healthcare sector's expanding budgets are facilitating investments in cutting-edge imaging equipment tailored for small animals, thereby enhancing research capabilities and accelerating advancements in veterinary medicine. This interplay of technological innovation and financial commitment is expected to create a favorable environment for the flourishing of the small animal imaging market in the foreseeable future.

Restraints in the Global Small Animal Imaging In Vivo Market

The Global Small Animal Imaging In Vivo market faces several challenges that could hinder its expansion. High equipment costs and technological constraints pose significant barriers to entry and progress. Additionally, the shortage of skilled professionals in developing countries further exacerbates the situation. Coupled with insufficient research facilities and infrastructure, these factors collectively limit the market's potential growth. As advancements continue in this field, addressing these issues will be crucial to ensuring a more robust and accessible small animal imaging environment for researchers and institutions. Without strategic solutions, the market may struggle to realize its full potential amidst these constraints.

Market Trends of the Global Small Animal Imaging In Vivo Market

The Global Small Animal Imaging In Vivo market is experiencing significant growth driven by an increasing demand for non-invasive imaging techniques among researchers and pharmaceutical companies. This surge is supported by enhanced funding from public and private organizations, fostering advancements across various disciplines such as chemistry, computer science, engineering, and molecular biology. Moreover, the expansion of research organizations and a focus on innovative technologies are propelling market dynamics. Emerging economies are likewise contributing to new growth opportunities, coupled with a strong emphasis on research and development initiatives, positioning the small animal imaging market for continued momentum and advancement.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Technology Advancement
  • Regulatory Landscape

Global Small Animal Imaging In Vivo Market Size by Modality & CAGR (2026-2033)

  • Market Overview
  • Optical Imaging Systems
    • Bioluminescence Imaging
    • Fluorescence Imaging
  • Nuclear Imaging Systems
    • Positron Emission Tomography (PET)
    • Single Photon Emission Computed Tomography (SPECT)
  • Magnetic Resonance Imaging (MRI) Systems
  • Computed Tomography (CT) Systems
  • Ultrasound Imaging Systems
  • Photoacoustic Imaging Systems

Global Small Animal Imaging In Vivo Market Size by Reagents & CAGR (2026-2033)

  • Market Overview
  • Optical Imaging Reagents
  • Nuclear Imaging Reagents
  • MRI Contrast Agents
  • Ultrasound Contrast Agents
  • CT Contrast Agents

Global Small Animal Imaging In Vivo Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Biodistribution Studies
  • Cancer Cell Detection
  • Biomarkers
  • Longitudinal Studies
  • Drug Development
  • Functional and Anatomical Imaging

Global Small Animal Imaging In Vivo Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Contract Research Organizations (CROs)
  • Hospitals and Clinics

Global Small Animal Imaging In Vivo Market Size & CAGR (2026-2033)

  • North America (Modality, Reagents, Application, End-User)
    • US
    • Canada
  • Europe (Modality, Reagents, Application, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Modality, Reagents, Application, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Modality, Reagents, Application, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Modality, Reagents, Application, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Bruker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FUJIFILM Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Miltenyi Biotec (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aspect Imaging (Israel)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mediso Ltd. (Hungary)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MR Solutions Ltd. (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TriFoil Imaging (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
  • Key Developments
  • Agilent Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canon Medical Systems Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations